RISING PHARMS FDA Approval ANDA 204928

ANDA 204928

RISING PHARMS

FDA Drug Application

Application #204928

Application Sponsors

ANDA 204928RISING PHARMS

Marketing Status

Prescription001
Prescription002

Application Products

001TABLET;ORAL10MG0ZAFIRLUKASTZAFIRLUKAST
002TABLET;ORAL20MG0ZAFIRLUKASTZAFIRLUKAST

FDA Submissions

UNKNOWN; ORIG1AP2022-08-25STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

RISING PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204928
            [companyName] => RISING PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"ZAFIRLUKAST","activeIngredients":"ZAFIRLUKAST","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ZAFIRLUKAST","activeIngredients":"ZAFIRLUKAST","strength":"20MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"08\/25\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-08-25
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.